PMC:7558233 / 19775-19942
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"504","span":{"begin":19,"end":23},"obj":"Gene"},{"id":"509","span":{"begin":124,"end":132},"obj":"Species"},{"id":"526","span":{"begin":115,"end":123},"obj":"Disease"},{"id":"527","span":{"begin":138,"end":146},"obj":"Disease"},{"id":"528","span":{"begin":148,"end":152},"obj":"Disease"},{"id":"529","span":{"begin":158,"end":161},"obj":"Disease"}],"attributes":[{"id":"A504","pred":"tao:has_database_id","subj":"504","obj":"Gene:59272"},{"id":"A509","pred":"tao:has_database_id","subj":"509","obj":"Tax:9606"},{"id":"A526","pred":"tao:has_database_id","subj":"526","obj":"MESH:C000657245"},{"id":"A527","pred":"tao:has_database_id","subj":"527","obj":"MESH:D003920"},{"id":"A528","pred":"tao:has_database_id","subj":"528","obj":"MESH:D029424"},{"id":"A529","pred":"tao:has_database_id","subj":"529","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Elevated levels of ACE2 that were proposed to be associated with an increased susceptibility have been observed in COVID-19 patients with diabetes, COPD, and CVD [58]."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T28","span":{"begin":148,"end":152},"obj":"Phenotype"}],"attributes":[{"id":"A28","pred":"hp_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/HP_0006510"}],"text":"Elevated levels of ACE2 that were proposed to be associated with an increased susceptibility have been observed in COVID-19 patients with diabetes, COPD, and CVD [58]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T113","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Elevated levels of ACE2 that were proposed to be associated with an increased susceptibility have been observed in COVID-19 patients with diabetes, COPD, and CVD [58]."}